Calpain 3 Antikörper (C-Term)
-
- Target Alle Calpain 3 (CAPN3) Antikörper anzeigen
- Calpain 3 (CAPN3)
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Calpain 3 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Aufreinigung
- Purified by antigen-specific affinity chromatography.
- Immunogen
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human CAPN3(Calpain-3)
- Top Product
- Discover our top product CAPN3 Primärantikörper
-
-
- Applikationshinweise
- ELISA, Western blotting: 1µg/ml for 2hrs.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- This antibody is stored in PBS, 50% glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- Calpain 3 (CAPN3)
- Andere Bezeichnung
- CAPN3 (CAPN3 Produkte)
- Hintergrund
- CAPN3(Calpain-3) is a calcium-regulated non-lysosomal thiol-protease. It has a broad endopeptidase specificity. CAPN3 is activated by micromolar concentrations of calcium and inhibited by calpastatin. It interacts with TTN/titin. Isoform I is skeletal muscle specific. Defects in CAPN3 are the cause of limb-girdle muscular dystrophy type 2A (LGMD2A). LGMD2A is both autosomal dominantly and recessively transmitted. It is characterized by progressive symmetrical atrophy and weakness of the proximal limb muscles and elevated serum creatine kinase. CAPN3 belongs to the peptidase C2 family and contains 1 calpain catalytic domain and 4 EF-hand domains.
- Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-